Payer Almanac
About the data Sign in
Star measuresDisplay measuresHEDISWhy members leave

Measures · D13 in 2015 · Part D · DD4 Drug Safety and Accuracy of Drug Pricing

Medication Adherence for Cholesterol (Statins)

Drug PlanMedication AdherenceSource: Prescription Drug Events

What it measures
One of the most important ways you can manage your health is by taking your medication as directed. The plan, the doctor, and the member can work together to find ways to help the member take their medication as directed. Percent of plan members with a prescription for a cholesterol medication (a statin drug) who fill their prescription often enough to cover 80% or more of the time they are supposed to be taking the medication.
How it's calculated
This measure is defined as the percent of Medicare Part D beneficiaries 18 years or older that adhere to their prescribed drug therapy for statin cholesterol medications. This percentage is calculated as the number of member-years of enrolled beneficiaries 18 years of older with a proportion of days covered (PDC) at 80 percent or over for statin cholesterol medication(s) during the measurement period (numerator) divided by the number of member-years of enrolled beneficiaries 18 years or older with at least two fills of either the same medication or medication in the drug class during the measurement period (denominator). The PDC is the percent of days in the measurement period “covered” by prescription claims for the same medication or another in the therapeutic category. Patients are only included in the measure calculation if the first fill of their medication occurs at least 91 days before the end of the enrollment period. The Medication Adherence measure is adapted from the Medication Adherence- Proportion of Days Covered measure that was developed and endorsed by the Pharmacy Quality Alliance (PQA). The PDC Adherence measures are also endorsed by the National Quality Forum (NQF). See the medication list for this measure. The Medication Adherence rate is calculated using the National Drug Code (NDC) list and obsolete NDC date methodology maintained by the PQA. The complete NDC list will be posted along with these technical notes. For the 2015 Star Ratings, NDCs with obsolete dates will be included in the measure calculation if their obsolete dates as reported by PQA are within the period of measurement (measurement year).
Data source
Prescription Drug Event (PDE) data; Medicare Enrollment Database (EDB) File; The data for this measure come from PDE data files submitted by drug plans to Medicare for January 1, 2013-December 31, 2013 by June 30, 2014. PDE claims are limited to members who received at least two prescriptions for a statin drug(s). PDE adjustments made post-reconciliation were not reflected in this measure.
Measurement period
01/01/2013 - 12/31/2013
Better when
Higher
Weight
3 (Intermediate Outcome Measure)
Star assignment
Relative Distribution and Clustering
Case-mix adjusted
—
In improvement measure
Yes
Used in CAI
—
Exclusions
ShowContracts with 30 or fewer beneficiary member years (in the denominator).
Notes
Part D drugs do not include drugs or classes of drugs, or their medical uses, which may be excluded from coverage or otherwise restricted under section 1927(d)(2) of the Act, except for smoking cessation agents. As such, these drugs, which may be included in the medication or NDC lists, are excluded from CMS analyses. Also, member-years of enrollment is the adjustment made by CMS to account for partial enrollment within the benefit year. Enrollment is measured at the spell level, and inclusion in the measure is determined separately for each spell – i.e., to be included for a given spell, the beneficiary must meet the initial inclusion criteria for the measure during that spell. The measure is weighted based on the total number of member years for each spell in which the beneficiary meets the measure criteria. For instance, if a beneficiary is enrolled for a three month spell, disenrolled for a six month spell, reenrolled for a three month spell, and meets the measure criteria during each enrollment spell , s/he will count as 0.5 member years in the rate calculation (3/12 + 3/12 = 6/12). The PDC calculation is adjusted for overlapping prescriptions for the same drug which is defined by active ingredient at the generic name level using the Medi-Span generic ingredient name. The calculation also adjusts for Part D beneficiaries’ stays in inpatient (IP) settings, hospice enrollments, and stays in skilled nursing facilities (SNFs). The SNF adjustment only applies to PDPs because SNF data are not currently available for MA-PDs. Please see Attachment L: Medication Adherence Measure Calculations for more information about these calculations.

From the 2015 Star Ratings Technical Notes (CMS).

Cut points over time

Score needed to earn each star level. Part D thresholds differ for MA-PD and standalone PDP contracts. Dotted lines and open dots: where the cut points may move for 2028.

How the 2028 cut points are projected

Each boundary moves by its median year-on-year change since 2019, capped at 5 points, the most CMS lets a non-survey cut point move in a year. It's the same projection the Star outlook uses for every contract. CMS sets real cut points from all contracts' scores each year, so treat these as a direction, not a forecast of the exact number.

StarsOrg type2027Projected 2028Move
2★MA-PD8487+3
3★MA-PD8889+1
4★MA-PD9091+1
5★MA-PD9394+1
2★PDP8687+1
3★PDP8889+1
4★PDP9091+1
5★PDP93930

2015 star distribution

Not rated: Plan too new to be measured (154); Plan not required to report measure (13); Not enough data available (11); No data available (4)

Cut point bands

Star yearOrg type1★2★3★4★5★
2027MA-PD< 84 %>= 84 % to < 88 %>= 88 % to < 90 %>= 90 % to < 93 %>= 93 %
2027PDP< 86 %>= 86 % to < 88 %>= 88 % to < 90 %>= 90 % to < 93 %>= 93 %
2026MA-PD< 84 %>= 84 % to < 88 %>= 88 % to < 90 %>= 90 % to < 93 %>= 93 %
2026PDP< 87 %>= 87 % to < 89 %>= 89 % to < 90 %>= 90 % to < 92 %>= 92 %
2025MA-PD< 80 %>= 80 % to < 85 %>= 85 % to < 89 %>= 89 % to < 93 %>= 93 %
2025PDP< 86 %>= 86 % to < 88 %>= 88 % to < 89 %>= 89 % to < 92 %>= 92 %
2024MA-PD< 82 %>= 82 % to < 86 %>= 86 % to < 88 %>= 88 % to < 91 %>= 91 %
2024PDP< 84 %>= 84 % to < 87 %>= 87 % to < 89 %>= 89 % to < 93 %>= 93 %
2023MA-PD< 81 %>= 81 % to < 85 %>= 85 % to < 88 %>= 88 % to < 92 %>= 92 %
2023PDP< 84 %>= 84 % to < 87 %>= 87 % to < 88 %>= 88 % to < 90 %>= 90 %
2022MA-PD< 78 %>= 78 % to < 83 %>= 83 % to < 87 %>= 87 % to < 91 %>= 91 %
2022PDP< 82 %>= 82 % to < 86 %>= 86 % to < 88 %>= 88 % to < 90 %>= 90 %
2021MA-PD< 75 %>= 75 % to < 83 %>= 83 % to < 86 %>= 86 % to < 88 %>= 88 %
2021PDP< 78 %>= 78 % to < 81 %>= 81 % to < 86 %>= 86 % to < 88 %>= 88 %
2020MA-PD< 72%? 72% to < 80%? 80% to < 84%? 84% to < 87%? 87%
2020PDP< 79%? 79% to < 83%? 83% to < 86%? 86% to < 88%? 88%
2019MA-PD< 73%? 73% to < 77%? 77% to < 83%? 83% to < 87%? 87%
2019PDP< 80%? 80% to < 82%? 82% to < 84%? 84% to < 88%? 88%
2018MA-PD< 66%? 66% to < 76%? 76% to < 80%? 80% to < 85%? 85%
2018PDP< 73%? 73% to < 79%? 79% to < 82%? 82% to < 86%? 86%
2017MA-PD< 66%? 66% to < 73%? 73% to < 77%? 77% to < 82%? 82%
2017PDP< 70%? 70% to < 74%? 74% to < 80%? 80% to < 84%? 84%
2016MA-PD< 50%? 50% to < 61%? 61% to < 73%? 73% to < 79%? 79%
2016PDP< 68%? 68% to < 73%? 73% to < 78%? 78% to < 83%? 83%
2015MA-PD< 59%? 59% to < 68%? 68% to < 76%? 76% to < 83%? 83%
2015PDP< 62%? 62% to < 69%? 69% to < 75%? 75% to < 78%? 78%

Lowest-scoring contracts, 2015

ContractParentMembersScoreStarsΔShortfall to 4★Pctile
H4011 MMM HEALTHCARE, LLC.InnovaCare Inc.—401—360%
H5887 MMM HEALTHCARE, INC.InnovaCare Inc.—401—360%
S2874 HumanaHumana Inc.—531—220%
H4211 AMGP GEORGIA MANAGED CARE COMPANY, INC.WellPoint, Inc.—451—310%
H2029 HumanaHumana Inc.0481—281%
H4005 Triple-S AdvantageGuidewell Mutual Holding Corporation6,490481—281%
H4004 Medicare y Mucho Mas (MMM)Elevance Health, Inc.101,304491—271%
H4003 Medicare y Mucho Mas (MMM)Elevance Health, Inc.94,108491—271%
H5774 Triple S AdvantageGuidewell Mutual Holding Corporation121,384521—242%
H4007 HumanaHumana Inc.—521—242%
S3474 HEARTLAND FIDELITY INSURANCE COMPANYHeartland Fidelity Insurance Company—622—132%
H5577 MCS ClassicareMHH Healthcare, L.P.361,020531—232%
H0913 WellcareCentene Corporation12,667541—222%
H4866 CUATRO LLCCuatro LLC.—571—192%
H5475 WellcareCentene Corporation18,951571—192%
H0908 WellcareCentene Corporation8,453571—192%
H0435 GLOBALHEALTH, INC.Kinderhook Capital Fund III, L.P.—592—173%
H3337 LIBERTY HEALTH ADVANTAGE, INC.Liberty Health Advantage, Inc.—602—163%
H2773 Quality Health Plans Of New York, Inc.QHP Financial Group, Inc.—602—163%
H5141 Clover HealthClover Health Holdings, Inc.156,154602—163%
S2505 WINDSOR HEALTH PLAN, INC.WellCare Health Plans, Inc.—652—104%
H5430 WellCareCentene Corporation—612—154%
H9285 ATLANTIS HEALTH PLAN, INC.America's 1st Choice NY Holdings, LLC—612—154%
H0901 AETNA HEALTH, INC. (PA)Aetna Inc.—622—144%
H5991 EmblemHealthEmblemHealth, Inc.2,285622—144%

History

Star yearCodeNameMeasuredWeightSource
2027D10Medication Adherence for Cholesterol (Statins)01/01/2025 – 12/31/20253Prescription Drug Events
2026D10Medication Adherence for Cholesterol (Statins)01/01/2024 – 12/31/20243Prescription Drug Events
2025D10Medication Adherence for Cholesterol (Statins)01/01/2023 – 12/31/20233Prescription Drug Events
2024D10Medication Adherence for Cholesterol (Statins)01/01/2022 – 12/31/20223Prescription Drug Events
2023D10Medication Adherence for Cholesterol (Statins)01/01/2021 – 12/31/20213Prescription Drug Events
2022D10Medication Adherence for Cholesterol (Statins)01/01/2020 – 12/31/20203Prescription Drug Events
2021D12Medication Adherence for Cholesterol (Statins)01/01/2019 – 12/31/20193Prescription Drug Events
2020D12Medication Adherence for Cholesterol (Statins)01/01/2018 – 12/31/20183Prescription Drug Events
2019D12Medication Adherence for Cholesterol (Statins)01/01/2017 – 12/31/20173Prescription Drug Events
2018D13Medication Adherence for Cholesterol (Statins)01/01/2016 – 12/31/20163Prescription Drug Events
2017D14Medication Adherence for Cholesterol (Statins)01/01/2015 - 12/31/20153Prescription Drug Events
2016D14Medication Adherence for Cholesterol (Statins)01/01/2014 - 12/31/20143Prescription Drug Events
2015D13Medication Adherence for Cholesterol (Statins)01/01/2013 - 12/31/20133Prescription Drug Events